Hurray for this FDA Reversal..A Positive Note in Beating Melanoma
Doctors have had few tools in their fight to tackle melanoma, so here’s a toast to Mela Sciences, and its chief executive, Joseph Gulfo for pursuing a seven-year battle with the FDA. Undaunted by last year’s rejection of the MelaFind, the company filed a citizen’s petition to the FDA.
WSJ’s Tom Burton has the exclusive story of the FDA approving the MelaFind device…and it’s an exciting story!
View the story here